Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis

Kahvecioglu, Serdar; Dilek, Kamil; Akdag, Ibrahim; Gullulu, Mustafa; Demircan, CELALEDDİN; Ersoy, ALPARSLAN; Yurtkuran, Mustafa

doi:10.1111/j.1440-1797.2006.00562.x

Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis

Copy For Citation

Kahvecioglu S., Dilek K., Akdag I., Gullulu M., Demircan C., Ersoy A., ...More

NEPHROLOGY, vol.11, no.3, pp.232-237, 2006 (SCI-Expanded)

Publication Type: Article / Article
Volume: 11 Issue: 3
Publication Date: 2006
Doi Number: 10.1111/j.1440-1797.2006.00562.x
Journal Name: NEPHROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.232-237
Bursa Uludag University Affiliated: Yes

Abstract

Aims: Because the cardiovascular system (CVS) side-effects of cyclooxygenase-2 (COX-2) selective inhibitors have recently been questioned, we aimed to compare the renal and haemodynamic effects of cyclooxygenase selective (celecoxib and rofecoxib) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) (indomethacin) in patients with renal amyloidosis secondary to rheumatological diseases who required anti-inflammatory agents and are taking maximum tolerable dose of angiotensin-converting enzyme inhibitors.